Citations for
1ICS23, LRRC6, ZMYND10
ZMYND10 Is Mutated in Primary Ciliary Dyskinesia and Interacts with LRRC6.
Zariwala MA, Gee HY, Kurkowiak M, Al-Mutairi DA, Leigh MW, Hurd TW, Hjeij R, Dell SD, Chaki M, Dougherty GW, Adan M, Spear PC, Esteve-Rudd J, Loges NT, Rosenfeld M, Diaz KA, Olbrich H, Wolf WE, Sheridan E, Batten TF, Halbritter J, Porath JD, Kohl S, Lovric S, Hwang DY, Pittman JE, Burns KA, Ferkol TW, Sagel SD, Olivier KN, Morgan LC, Werner C, Raidt J, Pennekamp P, Sun Z, Zhou W, Airik R, Natarajan S, Allen SJ, Amirav I, Wieczorek D, Landwehr K, Nielsen K, Schwerk N, Sertic J, Köhler G, Washburn J, Levy S, Fan S, Koerner-Rettberg C, Amselem S, Williams DS, Mitchell BJ, Drummond IA, Otto EA, Omran H, Knowles MR, Hildebrandt F.
Am J Hum Genet m J Hum Genet. 2013 Jul 24. doi:pii: S0002-9297(13)00276-0. 10.1016/j.ajhg.2013.06.007. [Epub ahead of print] 2013
2ZMYND10
Loss of heterozygosity and methylation of multiple tumor suppressor genes on chromosome 3 in hepatocellular carcinoma.
Zhang X, Li HM, Liu Z, Zhou G, Zhang Q, Zhang T, Zhang J, Zhang C.
J Gastroenterol 48(1):132-43. doi: 10.1007/s00535-012-0621-0. Epub 2012 Jul 6. 2013
3ZMYND10
Tumor suppressor BLU inhibits proliferation of nasopharyngeal carcinoma cells by regulation of cell cycle, c-Jun N-terminal kinase and the cyclin D1 promoter.
Zhang X, Liu H, Li B, Huang P, Shao J, He Z.
BMC Cancer 12:267. doi: 10.1186/1471-2407-12-267. 2012
4SMEK1, ZMYND10
Tumor suppressor BLU enhances pro-apoptotic activity of sMEK1 through physical interaction.
Dong SM, Byun HJ, Kim BR, Lee SH, Trink B, Rho SB.
Cell Signal 24(6):1208-14. doi: 10.1016/j.cellsig.2012.02.002. Epub 2012 Feb 12. 2012
5ZMYND10
Tumor suppressor gene BLU is frequently downregulated by promoter hypermethylation in myelodysplastic syndrome.
Yang Y, Zhang Q, Xu F, Wu L, He Q, Li X.
J Cancer Res Clin Oncol 138(5):729-37. doi: 10.1007/s00432-012-1151-0. Epub 2012 Jan 15. 2012
6ZMYND10
High-resolution melting analysis of BLU methylation levels in gastric, colorectal, and pancreatic cancers.
Shao Y, Zhang W, Zhang C, Wu Q, Yang H, Zhang J, Guan M, Wan J, Yu B.
Cancer Invest 28(6):642-8. doi: 10.3109/07357901003631023. 2010
7RASSF1A, ZMYND10
RASSF1A, BLU, NORE1A, PTEN and MGMT expression and promoter methylation in gliomas and glioma cell lines and evidence of deregulated expression of de novo DNMTs.
Lorente A, Mueller W, Urdangarín E, Lázcoz P, Lass U, von Deimling A, Castresana JS.
Brain Pathol 19(2):279-92. doi: 10.1111/j.1750-3639.2008.00185.x. Epub 2008 Jun 25. 2009
8ZMYND10
Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas.
Yi Lo PH, Chung Leung AC, Xiong W, Law S, Duh FM, Lerman MI, Stanbridge EJ, Lung ML.
Cancer Lett 234(2):184-92. 2006
9ZMYND10
Functional studies of the chromosome 3p21.3 candidate tumor suppressor gene BLU/ZMYND10 in nasopharyngeal carcinoma.
Yau WL, Lung HL, Zabarovsky ER, Lerman MI, Sham JS, Chua DT, Tsao SW, Stanbridge EJ, Lung ML.
Int J Cancer 119(12):2821-6. 2006
10RASSF1, ZMYND10
Hypermethylation of RASSF1A and BLU tumor suppressor genes in non-small cell lung cancer: implications for tobacco smoking during adolescence.
Marsit CJ, Kim DH, Liu M, Hinds PW, Wiencke JK, Nelson HH, Kelsey KT.
Int J Cancer 114(2):219-23. 2005
11ZMYND10
The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
Qiu GH, Tan LK, Loh KS, Lim CY, Srivastava G, Tsai ST, Tsao SW, Tao Q.
Oncogene 23(27):4793-806. 2004
12ZMYND10
Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.
Agathanggelou A, Dallol A, Zochbauer-Muller S, Morrissey C, Honorio S,Hesson L, Martinsson T, Fong KM, Kuo MJ, Yuen PW, Maher ER, Minna JD, Latif F.
Oncogene 22(10):1580-8. 2003
13ZMYND10, TSG3B
Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma.
Liu XQ, Chen HK, Zhang XS, Pan ZG, Li A, Feng QS, Long QX, Wang XZ, Zeng YX.
Int J Cancer 106(1):60-5. 2003